The Retinal Dopaminergic Circuit as a Biomarker for Huntington’s and Alzheimer’s Diseases
Open Access
- 10 June 2025
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (12) , 5532
Abstract
Retinal dysfunction is emerging as a potential early marker of neurodegenerative diseases. Within the retina, the dopaminergic circuit, comprising dopaminergic amacrine cells, dopamine synthesis and turnover, and dopamine receptor signalling, is essential for visual processing, particularly colour contrast perception. Disruption of this circuit may underline early retinal alterations observed in Huntington’s disease (HD) and Alzheimer’s disease (AD). In this study, we systematically analysed retinal dopaminergic dysfunction in murine models of HD (genetic origin) and AD (sporadic), across different disease stages. We assessed dopamine levels, turnover, tyrosine hydroxylase expression, D1 and D2 receptor gene expression, and neurotransmitter balance. HD mice showed early and marked alterations: reduced dopamine content, decreased tyrosine hydroxylase, increased turnover, and downregulation of D1 receptor expression—all preceding motor symptoms and detectable brain pathology. In contrast, AD mice showed only mild changes at later stages; however, clinical evidence suggests that similar dysfunction may occur earlier in human AD. These findings position retinal dopaminergic disruption as a potential early biomarker in HD and possibly in AD. While the current study relies on invasive techniques in animal models, it lays the groundwork for non-invasive retinal assessments, such as electroretinography or optical coherence tomography, as promising tools for early diagnosis and disease monitoring in neurodegeneration.Keywords
Funding Information
- Instituto de Salud Carlos III (ISCIII) (PI22/01588, PID2022-137331OB-C32)
- Ministerio de Ciencia e Innovación (PI22/01588, PID2022-137331OB-C32)
This publication has 74 references indexed in Scilit:
- 2024 Alzheimer's disease facts and figuresAlzheimer's & Dementia, 2024
- Primary retinal tauopathy: A tauopathy with a distinct molecular patternAlzheimer's & Dementia, 2023
- Thicker macula in asymptomatic APOE Ɛ4 middle‐aged adults at high AD riskAlzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2022
- Association of Retinal Changes With Alzheimer Disease Neuroimaging Biomarkers in Cognitively Normal IndividualsJAMA Ophthalmology, 2021
- Association of Retinal Nerve Fiber Layer Thinning With Current and Future Cognitive DeclineJAMA Neurology, 2018
- Melanopsin retinal ganglion cell loss in Alzheimer diseaseAnnals of Neurology, 2015
- Retinal alterations in mild cognitive impairment and Alzheimer’s disease: an optical coherence tomography studyJournal of Neurology, 2014
- Is the retina affected in Huntington disease?Acta Neuropathologica, 2005
- Fine‐structural analysis and connexin expression in the retina of a transgenic model of Huntington's diseaseJournal of Comparative Neurology, 2004
- Abnormal pattern electroretinogram in Alzheimer's disease: Evidence for retinal ganglion cell degeneration?Annals of Neurology, 1989